What evidence‑based information should be given to young adults in their 20s to discourage cannabis use?

Evidence-Based Information to Deter Cannabis Use in Young Adults

Young adults in their 20s should be informed that cannabis use during this critical neurodevelopmental period is associated with neuropsychological decline, elevated risk for psychotic disorders and depression, suicidal ideation, and cannabis use disorder—with those initiating use at younger ages facing substantially higher risks for developing addiction. 1

Key Messages Prioritized by Morbidity and Mortality

Mental Health Risks (Highest Priority)

Brain development and psychiatric consequences represent the most serious long-term harms for this age group:

• Cannabis use in early youth is associated with neuropsychological and neurodevelopmental decline that can persist into adulthood 1
• There is an elevated risk for psychotic disorders in adulthood, with high-potency THC products (now averaging 17% THC, up from 9% in 2008) particularly associated with psychosis 1
• Major depression and suicidal ideation are associated with even non-disordered cannabis use 1
• People who initiate cannabis use at a young age have an elevated risk for developing cannabis use disorder (CUD), a formally recognized condition with withdrawal symptoms including irritability, insomnia, and headaches 1

This is critical because 38% of young adults aged 18-25 report past-year cannabis use, making this the highest-risk age group 1.

Cardiovascular and Respiratory Mortality Risks

Acute life-threatening events should be emphasized:

• Cannabis smoking is associated with myocardial infarction and stroke 1
• Recent evidence shows increased risk for new-onset arrhythmia within 180 days of medical cannabis use 1
• Chronic bronchitis and COPD are associated with cannabis smoking, though the lung cancer link remains unclear 1
• Thousands were hospitalized for acute lung injury in 2019 from vaping THC products, particularly those from informal sources; the CDC and FDA explicitly recommend against using THC-containing vaping products from friends, family, or dealers 1

Addiction Potential

The risk of cannabis use disorder is substantial and dose-dependent:

• Regular cannabis users are at risk for developing CUD, with THC having "high potential for misuse" according to SAMHSA 1
• Young adults using cannabis equally for medical and recreational purposes show greater use disorder symptoms compared to other use patterns 2
• Cannabis norms in social environments (parents, peers, partners, community) are independently associated with frequent use and cannabis use disorder, with adjusted odds ratios of 5.58 and 2.48 respectively 3

Safety and Functional Impairment

Immediate safety risks that affect quality of life:

• Cannabis impairs reaction time and coordination, affecting driving ability 1
• Driving under the influence of cannabis (DUIC) is particularly elevated among those using for both medical and recreational purposes 2
• Short-term effects include anxiety, memory impairment, elevated heart rate and blood pressure 1

Addressing Common Misconceptions

"Medical" Cannabis Is Not Safer

Young adults often conflate medical and recreational use. Emphasize that:

• There is no quality evidence of efficacy for common pain conditions like back pain, chronic radiculopathy, or neuropathic pain 4
• The only FDA-approved cannabis-derived medication (Epidiolex) is for rare forms of epilepsy—not for conditions young adults typically claim 1
• Using cannabis "equally for medical and recreational purposes" correlates with greater mental health concerns and problematic use 2

High-Potency Products Are Increasingly Dangerous

Modern cannabis is not what previous generations used:

• THC concentrations have nearly doubled from 9% to 17% in plants, with concentrates reaching 70% THC 1
• High doses of THC are associated with psychosis 1
• Edibles pose unique risks with unintentional exposures increasing from 207 cases in 2017 to 3,054 in 2021 1

Effective Communication Strategies

Use Motivational Approaches, Not Scare Tactics

Based on intervention evidence:

• Motivational interventions more consistently reduce cannabis use compared to school-based prevention programs 5
• Brief interventions using motivational interviewing show modest, short-term effects on cannabis use 6
• Adolescents and young adults do not have to be addicted to benefit from intervention—early discussion is appropriate 6

Normalize the Conversation

• Young adults increasingly expect knowledgeable health care providers to discuss substance use 7
• One in six adolescents who experiments with cannabis goes on to misuse it, making early identification critical 7
• Screening tools like the Cannabis Use Disorder Identification Test-Revised (CUDIT-R) can structure discussions 8

Common Pitfalls to Avoid

1. Don't dismiss concerns about "just cannabis"—the evidence for serious psychiatric and cardiovascular morbidity is substantial
2. Don't equate historical cannabis use with current products—potency has dramatically increased
3. Don't assume medical use is evidence-based—there is no quality evidence for typical conditions young adults claim
4. Don't ignore the social environment—norms from parents, peers, and partners are more predictive than legal status 3

Special Populations Requiring Extra Caution

• Pregnant individuals: Cannabis may negatively affect fetal brain development and increase premature birth risk; the U.S. Surgeon General and FDA advise complete avoidance 1
• Those with family history of psychotic disorders: Elevated baseline risk combined with cannabis-associated psychosis risk
• Safety-sensitive workers: Cannabis use is not recommended for those in safety-sensitive positions 4